Imagu

Tel Aviv, Israel Founded: 2005 • Age: 21 yrs Acquired By ICarbonX
Object recognition software is developed for multiple industries.

About Imagu

Imagu is a Healthcare company based in Tel Aviv (Israel) founded in 2005, and was acquired by ICarbonX in September 2016. Object recognition software is developed for multiple industries. It operates in the Healthcare, Technology, and Industrial Goods & Manufacturing sectors. Imagu offers products and services including Object Recognition Software and Image Analysis Tools. Its focus areas include High Tech, Image Recognition, Object Recognition and HealthTech. Its legal entity is Imagu Vision Technologies Ltd.

Company details

Founded in 2005 in Tel Aviv, Israel, object recognition software is produced for sectors including semiconductors, homeland security, medical devices, and e-commerce. Image understanding capabilities are applied to digital images and videos, with segmentation tools developed for retinal blood vessel analysis to support diagnosis of conditions like diabetes, hypertension, and arteriosclerosis. Detection of objects, border identification, and feature measurements are enabled through the technology.

  • Headquarters Tel Aviv, Israel
  • Stage Acquired
  • Sectors
    Healthcare
    Technology Industrial Goods & Manufacturing
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website imagutech.com
  • Acquired by ICarbonX (Sep 2016)
  • Legal Name Imagu Vision Technologies Ltd
Key Metrics

Products & Services of Imagu

Imagu offers a comprehensive portfolio of products and services, including Object Recognition Software and Image Analysis Tools.

Object Recognition Software
Software Platform

AI tool for detecting and identifying objects in images and video.

Image Analysis Tools
AI Solutions

Software for measuring object features in various industrial applications.

Investors in Imagu

Imagu has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ICarbonX.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Bioinformatics platforms are provided for health management and drug development.
2015icarbonx.comShenzhen, China
Premium access

Investor details for Imagu

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Imagu

2 dated milestones of Imagu across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Imagu is founded.
  2. Exit Acquired by ICarbonX.

Web traffic of Imagu

Websites that share an audience with Imagu (imagutech.com).

Similar websites

Websites whose visitors overlap most with Imagu. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
google.com
100%
85.8B#1View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Imagu

Imagu was founded in 2005.

Imagu is headquartered in Tel Aviv, Israel.

Founded in 2005 in Tel Aviv, Israel, object recognition software is produced for sectors including semiconductors, homeland security, medical devices, and e-commerce. Image understanding capabilities are applied to digital images and videos, with segmentation tools developed for retinal blood vessel analysis to support diagnosis of conditions like diabetes, hypertension, and arteriosclerosis. Detection of objects, border identification, and feature measurements are enabled through the technology.

Imagu offers Object Recognition Software and Image Analysis Tools.

Imagu has 1 investor. Key investors include ICarbonX.

Imagu operates through Imagu Vision Technologies Ltd.

Yes. Imagu was acquired by ICarbonX in September 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available